Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil, a blood pressure drug, can cause excessive hair growth, but this can be successfully treated with a hair removal agent called calcium thioglycolate.

Lithium can cause skin discoloration even at normal levels, so monitor for signs of intoxication.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Idiopathic hypoparathyroidism is rare and can be managed with dihydrotachysterol.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

A woman experienced hair loss after taking strontium ranelate for osteoporosis.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

Vitamin A toxicity can cause severe health issues and may require a liver transplant if other treatments fail.

New isatin-gallate hybrids show promise as antioxidants, cancer treatments, and coronavirus inhibitors.

Hair loss can be a side effect of certain blood thinners.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Taking too much vitamin A can cause health problems like bone pain and hair loss.

Baricitinib and tofacitinib have different safety patterns in treating alopecia areata.

Sodium selenate was found to be safe and possibly slows Alzheimer's progression, but more research is needed.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Advanced delivery systems can make dithranol more effective and less irritating for treating psoriasis.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Compounds from turmeric and bitter show strong potential as antiviral agents against the influenza A virus.